Arylomycin A2
Arylomycin A2, an antibiotic (Antibiotic), is a lipopeptide type I signal peptidase (SPase I) inhibitor. Arylomycin A2 has antibacterial effects[1].
Product Specifications
CAS Number
459844-20-3
UNSPSC
12352209
Target
Antibiotic; Bacterial
Type
Peptides
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/arylomycin-a2.html
Purity
97.37
Solubility
10 mM in DMSO
Smiles
O=C([C@H]1NC([C@H](C)NC([C@@H](N(C)C(CNC([C@@H](C)NC([C@@H](CO)N(C)C(CCCCCCCCC(C)C)=O)=O)=O)=O)C2=CC=C(C(C3=CC(C1)=CC=C3O)=C2)O)=O)=O)O
Molecular Formula
C42H60N6O11
Molecular Weight
824.96
References & Citations
[1]Mark Paetzel, et al. Crystallographic and biophysical analysis of a bacterial signal peptidase in complex with a lipopeptide-based inhibitor. J Biol Chem. 2004 Jul 16;279 (29) :30781-90. |[2]Katrijn Bockstael, et al. Evaluation of the type I signal peptidase as antibacterial target for biofilm-associated infections of Staphylococcus epidermidis. Microbiology (Reading) . 2009 Nov;155 (Pt 11) :3719-3729.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Peptides
Clinical Information
No Development Reported
Isoform
Lipopeptide
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog